NBJ
Natrol’s Bos, Balbert on Plethico Pharmacueticals deal

Natrol’s Bos, Balbert on Plethico Pharmacueticals deal

Natrol's Wayne Bos, Elliott Balbert speak with NBJ following firm's acquisition by Plethico Pharmaceuticals.

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.